Candela Receives Registration Approval to Market the Latest Generation of Vbeam Lasers in China
07 Abril 2009 - 9:27AM
Business Wire
Candela Corporation (NASDAQ:CLZR) today announced that it has
received registration approval from the Chinese State Food and Drug
Administration (SFDA) to market the full line of Vbeam� lasers in
the People�s Republic of China.
�We are delighted about the opportunity to now be able to offer
the latest generation pulsed dye laser to the market in the
People�s Republic of China.� said Candela President and Chief
Executive Officer, Gerard E. Puorro. �With this approval, many of
our products are now successfully being marketed in China, enabling
us to offer the Chinese medical community a more comprehensive
range of aesthetic laser solutions.�
Gerard E. Puorro added: �We are also honored to have a
delegation of physicians from the People�s Republic of China visit
the Candela corporate offices and factory in Wayland, Massachusetts
on Tuesday, April 7, 2009. Through our partners, Chindex
International, Inc., we have been working closely with the Chinese
registration authorities and we hope to receive further approvals
for additional products over the next several months.�
The Vbeam pulsed dye laser has an unparalleled 25-year proven
track record of safety, reliability and efficacy for the treatment
of a wide range of vascular conditions. The latest generation Vbeam
features advanced micro-pulse technology, multiple handpieces, and
a patented Dynamic Cooling Device� (DCD�) allowing for fast and
comfortable treatments, which is a particularly important factor
when treating infants and children.
For more information visit http://www.candelalaser.com.
About
CANDELA: Candela Corporation manufactures and
distributes innovative clinical solutions that enable physicians,
surgeons, and personal care practitioners to treat selected
cosmetic and medical conditions using lasers, aesthetic laser
systems, and other advanced technologies. Founded near Boston in
1970, Candela markets and services its products in 86 countries
from offices and distributors in the United States, Europe, Japan,
China and other Asian locations. Candela established the aesthetic
laser market 20 years ago, and currently has an installed base of
over 13,500 systems worldwide. Visit Candela on the Web at
http://www.candelalaser.com.
Safe Harbor
Statement: Except for the historical information
contained herein, this news release contains forward-looking
statements that constitute Candela Corporation�s current
intentions, hopes, beliefs, expectations or predictions of the
future, which are therefore inherently subject to risks and
uncertainties. These statements include declarations regarding our
or our management�s beliefs and current expectations. In some
cases, you can identify forward-looking statements by terminology
such as �may,� �will,� �should,� �expects,� �plans,� �anticipates,�
�believes,� �estimates,� �predicts,� �potential� or �continue� or
the negative of such terms or other comparable terminology. These
forward-looking statements are subject to inherent risks and
uncertainties in predicting future results and conditions that
could cause the actual results to differ materially from those
projected in these forward-looking statements. The risks and
uncertainties that may affect forward-looking statements include,
among others: the availability of, and our ability to successfully
implement strategic and operational alternatives, the pendency of
re-examinations of the �844 Patent and the �568 Patent before the
PTO, our alleged infringement of the �844 Patent and the �568
Patent, the validity of the �844 Patent and the �568 Patent, our
expected legal expenses, our exploration of strategic and
operational alternatives, the expected recovery of our industry,
our future revenue, gross margin, expense levels and earnings, our
growth prospects, market acceptance of our products, the strength
of our distribution channels, our ability to add new products, our
ability to expand regulatory approvals and the liquidity of our
common stock, the cancellation or deferral of customer orders, the
risk of a material adverse judgment or increased litigation-related
expenses in pending litigation matters, dependence on a small
number of strategic distribution relationships, difficulties in the
timely development and market acceptance of new products,
unanticipated increases in expenses, market developments that vary
from the current public expectations concerning the growth of the
laser industry, increased competitive pressures, changes in
economic conditions, or difficulties in obtaining timely regulatory
approvals. Further information on factors that could affect
Candela's performance is included in Candela's periodic reports
filed with the SEC. Candela cautions readers not to place undue
reliance upon any such forward-looking statements, which speak only
as of the date made. Candela expressly disclaims any obligations or
undertaking to release publicly any updates or revisions to any
such statements to reflect any change in Candela's expectations or
any change in events, conditions or circumstances on which any such
statement is based.
Candela (MM) (NASDAQ:CLZR)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Candela (MM) (NASDAQ:CLZR)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024